INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$3.0M

$2,984,770

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
VRTX S VERTEX PHARMACEUTICALS INC / MA Bunnage Mark E. • Officer • EVP, Chief Scientific Officer 10b5-1 Sell 2026-02-25 $301,537 View Form 4 →
VRTX	VERTEX PHARMACEUTICALS INC / MA	Bunnage Mark E. Officer • EVP, Chief Scientific Officer 10b5-1 Sell	2026-02-25	$301,537	S	Form 4
VRTX S VERTEX PHARMACEUTICALS INC / MA Bunnage Mark E. • Officer • EVP, Chief Scientific Officer 10b5-1 SellΔOwn -12.2% 2026-02-18 $559,890 View Form 4 →
VRTX	VERTEX PHARMACEUTICALS INC / MA	Bunnage Mark E. Officer • EVP, Chief Scientific Officer 10b5-1 SellΔOwn -12.2%	2026-02-18	$559,890	S	Form 4
VRTX S VERTEX PHARMACEUTICALS INC / MA Bunnage Mark E. • Officer • EVP, Chief Scientific Officer 10b5-1 SellΔOwn -20.1% 2026-02-17 $1,192,814Large View Form 4 →
VRTX	VERTEX PHARMACEUTICALS INC / MA	Bunnage Mark E. Officer • EVP, Chief Scientific Officer 10b5-1 SellΔOwn -20.1%	2026-02-17	$1,192,814Large	S	Form 4
VRTX S VERTEX PHARMACEUTICALS INC / MA Bunnage Mark E. • Officer • EVP, Chief Scientific Officer 10b5-1 SellΔOwn -13.5% 2026-02-11 $930,529 View Form 4 →
VRTX	VERTEX PHARMACEUTICALS INC / MA	Bunnage Mark E. Officer • EVP, Chief Scientific Officer 10b5-1 SellΔOwn -13.5%	2026-02-11	$930,529	S	Form 4